Evidence map›Paper›PMID 27171268›Full record

ArticlePloS one2016

Knee Joint Distraction Compared to Total Knee Arthroplasty for Treatment of End Stage Osteoarthritis: Simulating Long-Term Outcomes and Cost-Effectiveness.

J A D van der Woude, S C Nair, R J H Custers, J M van Laar, N O Kuchuck, F P J G Lafeber, P M J Welsing

Open access · goldAbstract readComparative StudyMulticenter Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

J A D van der WoudeDepartment of Orthopedics, Maartenskliniek Woerden, Woerden, The Netherlands.
S C NairDepartment of Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, The Netherlands.
R J H CustersDepartment of Orthopedics, UMC Utrecht, Utrecht, The Netherlands.
J M van LaarDepartment of Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, The Netherlands.
N O KuchuckDepartment of Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, The Netherlands.
F P J G LafeberDepartment of Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, The Netherlands.
P M J WelsingDepartment of Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, The Netherlands.
University Medical Center Utrecht · NLSint Maartenskliniek · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn end-stage knee osteoarthritis the treatment of choice is total knee arthroplasty (TKA). An alternative treatment is knee joint distraction (KJD), suggested to postpone TKA. Several studies reported significant and prolonged clinical improvement of KJD. To make an appropriate decision regarding the position of this treatment, a cost-effectiveness and cost-utility analysis from healthcare perspective for different age and gender categories was performed.

methodsA treatment strategy starting with TKA and a strategy starting with KJD for patients of different age and gender was simulated. To extrapolate outcomes to long-term health and economic outcomes a Markov (Health state) model was used. The number of surgeries, QALYs, and treatment costs per strategy were calculated. Costs-effectiveness is expressed using the cost-effectiveness plane and cost-effectiveness acceptability curves.

resultsStarting with KJD the number of knee replacing procedures could be reduced, most clearly in the younger age categories; especially revision surgery. This resulted in the KJD strategy being dominant (more effective with cost-savings) in about 80% of simulations (with only inferiority in about 1%) in these age categories when compared to TKA. At a willingness to pay of 20.000 Euro per QALY gained, the probability of starting with KJD to be cost-effective compared to starting with a TKA was already found to be over 75% for all age categories and over 90-95% for the younger age categories.

conclusionA treatment strategy starting with knee joint distraction for knee osteoarthritis has a large potential for being a cost-effective intervention, especially for the relatively young patient.

Indexed as

Cost-Benefit AnalysisAgedArthroplasty, Replacement, KneeComputer SimulationFemaleHumansKnee JointMaleOsteoarthritis, KneeOsteogenesis, DistractionPatient Acceptance of Health CareQuality-Adjusted Life YearsTreatment Outcome

Identifiers

PMID27171268
PMCPMC4865158
OpenAlexW2356845749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.